China Drug Makers Move To R&D Ties With MNCs Such As Pfizer, Bristol
This article was originally published in PharmAsia News
Executive Summary
Chinese drug makers are seeking a change in specialties that multinational pharmaceutical companies target when they seek local collaborations, from one on sales tie-ups to research and development.